Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Patient Version - National Cancer Institute

Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Patient Version - National Cancer Institute

Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Patient Version

Go to Health Professional Version

ON THIS PAGE

• General Information About Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer
• Stages of Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer
• Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer
• Treatment Option Overview
• Treatment Options by Stage
• Treatment Options for Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer
• To Learn More About Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer
• About This PDQ Summary

General Information About Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer

KEY POINTS

• Ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer are diseases in which malignant (cancer) cells form in the tissue covering the ovary or lining the fallopian tube or peritoneum.
• Ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer form in the same type of tissue and are treated the same way.
• Women who have a family history of ovarian cancer are at an increased risk of ovarian cancer.
• Some ovarian, fallopian tube, and primary peritoneal cancers are caused by inherited gene mutations (changes).
• Women with an increased risk of ovarian cancer may consider surgery to lessen the risk.
• Signs and symptoms of ovarian, fallopian tube, or peritoneal cancer include pain or swelling in the abdomen.
• Tests that examine the ovaries and pelvic area are used to detect (find), diagnose, and stage ovarian, fallopian tube, and peritoneal cancer.
• Certain factors affect treatment options and prognosis (chance of recovery).